Back to Results
First PageMeta Content
Viral vector / Vector / HEK cell / Feline immunodeficiency virus / Helper virus / Virus / Retinal gene therapy using lentiviral vectors / Vectors in Gene Therapy / Biology / Gene delivery / Molecular biology


First National Gene Transfer Safety Symposium: Internally Deleted, Helper-Dependent Adenoviral Vectors March 8, 2000 INTRODUCTION In March 2000, as part of ongoing efforts to enhance the protection of research participan
Add to Reading List

Document Date: 2013-12-10 12:40:23

Open Document

File Size: 29,20 KB

Share Result on Facebook

Company

GenStar Therapeutics Corporation/Urogen Corporation / Dr. Wei-Wei Zhang / /

Event

Product Issues / /

Facility

University of North Carolina School / University of Michigan / McMaster University / /

IndustryTerm

treatment of chronic diseases / vector product / Hemophilia Treatment / transgene product / treatment of polygenic diseases / viral products / vector systems / /

MedicalCondition

suitable candidate disease / chronic immunogenecity response / hemophilia A / Severe Hemophilia / mild hemophilia / polygenic diseases / diseases / specific disease / chronic diseases / suitable disease / hemophilia / disorders / /

MedicalTreatment

intravenous infusion / /

Organization

National Institute of Health / McMaster University / Hemophilia Treatment Center / University of Michigan / FDA / NIH OBA / Recombinant DNA Advisory Committee / NIH office of Biotechnology Activities / Department of Health and Human Services / University of North Carolina School of Medicine / /

Person

Anne Pilaro / Jeffery Chamberlain / Dale Ando / Frank Graham / Estuardo Aguilar-Cordova / Gilbert White II / /

Position

Principal Investigator / model for the HHS initiative / reporter / /

Product

RCA / vector particles / /

ProvinceOrState

Michigan / /

PublishedMedium

The RAC review / /

Technology

3 The protocol / antibodies / Biotechnology / gene expression / recombination / Recombinant DNA / /

URL

http /

SocialTag